FIELD: medicine.
SUBSTANCE: prediction of the clinical course of endocrine ophthalmopathy in the patients suffering Graves disease is ensured by detecting a pre-radio-iodine-therapy anti-thyroid peroxidase antibody in blood serum. The presence of the antibodies enables predicting a manifested and prolonged inflammatory process and maintaining a level of activity of the clinical course of endocrine ophthalmopathy.
EFFECT: using said method enables predicting the clinical course of endocrine ophthalmopathy in the patients with Graves disease, and prescribing well-timed and adequate treatment of the patients suffering said pathology.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ENDOCRINE OPHTHALMOPATHY EARLIEST MANIFESTATIONS DIAGNOSING | 2016 |
|
RU2617198C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RELAPSE IN THE MEDICAL TREATMENT OF GRAVES' DISEASE | 2021 |
|
RU2778614C1 |
| METHOD FOR PREDICTING RADIOIODINE THERAPY FOR GRAVES' DISEASE | 2022 |
|
RU2791390C1 |
| METHOD OF TREATING ENDOCRINE AUTOIMMUNE OPHTHALMOPATHY | 2024 |
|
RU2819981C1 |
| METHOD FOR PERSONALIZED APPROACH TO CHOOSING METHOD FOR TREATMENT OF GRAVES DISEASE | 2022 |
|
RU2794815C1 |
| METHOD OF ENDOCRINE OPHTHALMOPATHY TREATMENT | 2020 |
|
RU2725861C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DIFFERENT AUTOIMMUNE THYROID LESIONS | 2006 |
|
RU2315322C1 |
| METHOD FOR EARLY DIAGNOSIS OF AN ACTIVE PHASE OF ENDOCRINE OPHTHALMOPATHY | 2018 |
|
RU2687082C1 |
| METHOD FOR INDIVIDUAL PRESCRIPTION OF SYSTEMIC GLUCOCORTICOSTEROID PULSE THERAPY IN PATIENTS WITH ENDOCRINAL OPHTHALMOPATHY | 2012 |
|
RU2503011C1 |
| METHOD OF COMBINED CONSERVATIVE TREATMENT OF ACTIVE ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2806503C1 |
